Continuous Glucose Monitoring Systems and Type 2 Diabetic Control
MetadataShow full item record
Background: In the United States, uncontrolled T2D has significant financial expenditure and can lead to multiple health complications for diabetic patients when left unaddressed. Standardizing a method of glucose monitoring for adults with T2D can help reduce overall national healthcare costs, improve patient morbidity, mortality rates, and quality of life, reduce monitoring noncompliance, and improve patient outcomes. Despite numerous evidence-based benefits, limited use of CGMS among adult T2D patients currently exists. Further research is needed to assess CGMS efficacy among adult TD2 patients. Purpose: The purpose of this Doctor of Nursing Practice (DNP) project was to conduct a retrospective chart review to assess the efficacy of continuous glucose monitoring systems (CGMS) in reducing A1C levels in adult patients with type 2 diabetes (T2D) in a Western New York (WNY) endocrinology center. Methods: A retrospective chart review was performed on 57 adult T2D patients from March 5th, 2021 through March 19th, 2021. Inclusion criteria included adults older than 18 years old who are T2D for greater than 12 months and have been prescribed a CGMS for at least 6 months. The Diffusion of Innovation theory was the theoretical framework used to guide the DNP project. Results: Results of this project revealed a mean reduction in A1C levels from 8.2% to 7.7% after application of the CGMS on the T2D. Conclusions and Implications: Findings resulting from this DNP project can contribute to the existing body of research supporting the benefits of utilizing CGMS for adult patients living with T2D and the need to implement CGMS as part of standardized diabetic care.